• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证韩国心房颤动人群中常规血栓栓塞危险因素 - 新型评分系统 CHADS-VAK 的建议。

Validation of Conventional Thromboembolic Risk Factors in a Korean Atrial Fibrillation Population - Suggestion for a Novel Scoring System, CHADS-VAK.

机构信息

Department of Internal Medicine, Seoul National University Hospital.

Department of Internal Medicine, Seoul National University Bundang Hospital.

出版信息

Circ J. 2018 Nov 24;82(12):2970-2975. doi: 10.1253/circj.CJ-18-0218. Epub 2018 Oct 4.

DOI:10.1253/circj.CJ-18-0218
PMID:30282848
Abstract

BACKGROUND

There is little evidence that focuses on the ethnic variability of clinical risk factors for thromboembolism (TE) in atrial fibrillation (AF). We aimed to investigate the effect of each traditional risk factor in the Korean AF population.

METHODS AND RESULTS

Medical records of 12,876 consecutive patients (aged >18 years) newly diagnosed and followed up with non-valvular AF from 2000 to 2013 were reviewed. TE events, including ischemic stroke and systemic embolism, were investigated for risk factor validation. Among the total of 12,876 patients, 1,390 (10.8%) had TE events. In univariate/multivariate analysis adjusting for clinical factors and antithrombotic medications, traditional risk factors included in the CHADS-VASc scheme showed statistical significance, except for female sex, which was not a predictor of events. Additionally, chronic kidney disease (CKD; hazard ratio 1.62, P<0.001) was shown to be an independent predictor of TE events. Based on the analysis, we developed a novel stratification system, CHADS-VAK, omitting the female sex category and adding CKD. The new scoring system showed greater discrimination in event rates between score 0 and 1 patients.

CONCLUSIONS

Female sex was not associated with TE events in a Korean non-valvular AF population. The novel CHADS-VAK scoring system, with substitution of CKD for female sex, might be more appropriate for the Korean population.

摘要

背景

目前针对房颤患者血栓栓塞(TE)的临床风险因素的种族差异,相关证据较少。我们旨在研究每种传统风险因素在韩国房颤人群中的作用。

方法和结果

回顾了 2000 年至 2013 年间连续 12876 例(年龄>18 岁)新诊断和随访的非瓣膜性房颤患者的病历。研究了 TE 事件(包括缺血性卒中和全身栓塞)的危险因素验证。在总共 12876 例患者中,有 1390 例(10.8%)发生了 TE 事件。在调整临床因素和抗血栓药物的单因素/多因素分析中,CHADS-VASc 方案中包含的传统危险因素具有统计学意义,但女性性别除外,其不是事件的预测因素。此外,慢性肾脏病(CKD;风险比 1.62,P<0.001)是 TE 事件的独立预测因素。在此基础上,我们开发了一种新的分层系统 CHADS-VAK,排除了女性类别,并添加了 CKD。新的评分系统在 0 分和 1 分患者之间的事件发生率方面显示出更好的区分度。

结论

在韩国非瓣膜性房颤人群中,女性性别与 TE 事件无关。新型 CHADS-VAK 评分系统用 CKD 替代女性,可能更适合韩国人群。

相似文献

1
Validation of Conventional Thromboembolic Risk Factors in a Korean Atrial Fibrillation Population - Suggestion for a Novel Scoring System, CHADS-VAK.验证韩国心房颤动人群中常规血栓栓塞危险因素 - 新型评分系统 CHADS-VAK 的建议。
Circ J. 2018 Nov 24;82(12):2970-2975. doi: 10.1253/circj.CJ-18-0218. Epub 2018 Oct 4.
2
CHADS-VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Korean Nationwide Sample Cohort Study.亚洲房颤患者卒中的CHADS-VASc评分(充血性心力衰竭、高血压、年龄≥75岁[加倍]、糖尿病、既往卒中或短暂性脑缺血发作[加倍]、血管疾病、年龄65 - 74岁、女性):一项韩国全国性样本队列研究。
Stroke. 2017 Jun;48(6):1524-1530. doi: 10.1161/STROKEAHA.117.016926. Epub 2017 Apr 28.
3
CHADS-VASc score as a predictor of long-term cardiac outcomes in elderly patients with or without atrial fibrillation.CHADS-VASc 评分作为老年伴有或不伴有房颤患者长期心脏结局的预测因子。
Clin Interv Aging. 2018 Mar 29;13:497-504. doi: 10.2147/CIA.S147916. eCollection 2018.
4
Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.肾功能障碍、卒中风险评分(CHADS2、CHA2DS2-VASc 和 R2CHADS2)与心房颤动导管消融术后血栓栓塞事件风险:莱比锡心脏中心房颤消融登记研究。
Circ Arrhythm Electrophysiol. 2013 Oct;6(5):868-74. doi: 10.1161/CIRCEP.113.000869. Epub 2013 Sep 18.
5
Pacemaker-detected atrial fibrillation burden and risk of ischemic stroke or thromboembolic events-A cohort study.起搏器检出的心房颤动负荷与缺血性卒中和血栓栓塞事件风险:一项队列研究。
Heart Lung. 2020 Jan-Feb;49(1):66-72. doi: 10.1016/j.hrtlng.2019.07.007. Epub 2019 Jul 31.
6
Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.评估 CHA2DS2-VASc 评分在伴有和不伴有心房颤动的心力衰竭患者中预测缺血性卒、血栓栓塞和死亡的价值。
JAMA. 2015 Sep 8;314(10):1030-8. doi: 10.1001/jama.2015.10725.
7
R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score.R2CHADS2 评分与 CHA2DS2-VASc 评分在房颤导管消融术后血栓栓塞事件中的比较。
Can J Cardiol. 2014 Apr;30(4):405-12. doi: 10.1016/j.cjca.2014.01.005. Epub 2014 Jan 13.
8
Stroke and Systemic Thromboembolism according to CHADS-VASc Score in Contemporary Korean Patients with Atrial Fibrillation.当代韩国心房颤动患者根据 CHADS-VASc 评分的卒中与全身性血栓栓塞
Yonsei Med J. 2022 Apr;63(4):317-324. doi: 10.3349/ymj.2022.63.4.317.
9
Risk of Ischemic Stroke in Patients With Non-Valvular Atrial Fibrillation Not Receiving Oral Anticoagulants - Korean Nationwide Population-Based Study.未接受口服抗凝剂治疗的非瓣膜性心房颤动患者发生缺血性卒中的风险——韩国全国基于人群的研究
Circ J. 2017 Jul 25;81(8):1158-1164. doi: 10.1253/circj.CJ-16-1267. Epub 2017 Apr 12.
10
Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHADS-VA Score Rather Than CHADS-VASc?女性性别是房颤卒中的风险修饰因素而非风险因素:我们是否应该使用 CHADS-VA 评分而不是 CHADS-VASc?
Circulation. 2018 Feb 20;137(8):832-840. doi: 10.1161/CIRCULATIONAHA.117.029081.

引用本文的文献

1
Enhancing the evaluation of acute ischemic stroke risk in individuals with non-valvular atrial fibrillation by including laboratory indicators.通过纳入实验室指标来增强对非瓣膜性心房颤动个体的急性缺血性卒中风险的评估。
Sci Rep. 2024 Mar 21;14(1):6844. doi: 10.1038/s41598-024-57497-x.
2
Comprehensive comparison of stroke risk score performance: a systematic review and meta-analysis among 6 267 728 patients with atrial fibrillation.综合比较中风风险评分表现:6267728 例房颤患者的系统评价和荟萃分析。
Europace. 2022 Nov 22;24(11):1739-1753. doi: 10.1093/europace/euac096.
3
Efficacy of RCHADS-VA score for predicting thromboembolism in Thai patients with non-valvular atrial fibrillation.
泰国非瓣膜性心房颤动患者 RCHADS-VA 评分预测血栓栓塞的有效性。
BMC Cardiovasc Disord. 2021 Nov 12;21(1):540. doi: 10.1186/s12872-021-02370-2.
4
Nomogram to Predict Left Atrial Thrombus or Spontaneous Echo Contrast in Patients With Non-valvular Atrial Fibrillation.预测非瓣膜性心房颤动患者左心房血栓或自发回声增强的列线图
Front Cardiovasc Med. 2021 Oct 14;8:737551. doi: 10.3389/fcvm.2021.737551. eCollection 2021.
5
A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation.非瓣膜性心房颤动患者缺血性卒中评估生物标志物综述
Front Cardiovasc Med. 2021 Jul 1;8:682538. doi: 10.3389/fcvm.2021.682538. eCollection 2021.
6
Antithrombotic management of patients with atrial fibrillation-Dutch anticoagulant initiatives anno 2020.2020年荷兰心房颤动患者的抗栓治疗——抗凝倡议
Neth Heart J. 2020 Aug;28(Suppl 1):19-24. doi: 10.1007/s12471-020-01446-6.